was successfully added to your cart.

Carrinho

Merck-Germany-Next-Gen-ADCs

Por 28 de outubro de 2021

A Merck lança novas tecnologias e expande a capacidade de promover terapias de conjugados anticorpo-fármaco (CAF).

Author PR Newswire

More posts by PR Newswire